Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
AKTX | US
Overview
Corporate Details
- ISIN(s):
- US00972G2075
- LEI:
- Country:
- United States of America
- Address:
- 401 EAST JACKSON STREET, 33602 TAMPA
- Website:
- https://www.akaritx.com/
- Sector:
- Manufacturing
Description
Akari Therapeutics Plc is an innovative targeted oncology company focused on developing next-generation antibody-drug conjugates (ADCs) and utilizing a novel discovery engine. The company's platform is built around proprietary cancer-killing toxins designed for targeted delivery to tumor cells. Its lead payload is PH1, which is engineered to create potent therapies for cancer treatment.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
|
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB
Full Filing History RestrictedAccess to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset. |
|||||
Automate Your Workflow. Get a real-time feed of all Akari Therapeutics Plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Akari Therapeutics Plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Akari Therapeutics Plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
